Lack of fluoridated water affects oral health of Queenslanders from lower socio-economic areas

Researchers have found Queenslanders from lower socio-economic areas are at higher risk of dental disease due to a lack of fluoridated water.

In Friday IPO doubleheader, Apogee and Sagimet help crack open a stuck window on Wall Street

Mark Friday, July 14, in biotech’s 2023 yearbook. Two drug developers, Apogee Therapeutics and Sagimet Biosciences, will join the Nasdaq in upsized offerings, a positive

July 14, 2023

#ASCO24: Novartis’ new CML treatment tops older drugs, including Gleevec, in Phase 3 trial

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 1, 2024

argenx’s VYVDURA gains approval in Japan for gMG treatment

Share this article argenx’s VYVDURA SC injection is indicated to treat generalised myasthenia gravis patients who have inadequate response to steroids or non-steroidal ISTs. Credit:

January 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.